Back to Journals » Drug Design, Development and Therapy » Volume 14

Metabolic Stability Assessment of New PARP Inhibitor Talazoparib Using Validated LC–MS/MS Methodology: In silico Metabolic Vulnerability and Toxicity Studies

Total article views   HTML views PDF downloads Totals
7,955 Dovepress* 7,062+ 1,041 8,103
PubMed Central* 893 205 1,098
Totals 7,955 1,246 9,201
*Since 25 February 2020
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar